These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 20087348)

  • 1. Reversal of gene expression changes in the colorectal normal-adenoma pathway by NS398 selective COX2 inhibitor.
    Galamb O; Spisák S; Sipos F; Tóth K; Solymosi N; Wichmann B; Krenács T; Valcz G; Tulassay Z; Molnár B
    Br J Cancer; 2010 Feb; 102(4):765-73. PubMed ID: 20087348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of methylated septin 9 gene on RNA and protein level in colorectal cancer.
    Tóth K; Galamb O; Spisák S; Wichmann B; Sipos F; Valcz G; Leiszter K; Molnár B; Tulassay Z
    Pathol Oncol Res; 2011 Sep; 17(3):503-9. PubMed ID: 21267688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA hypermethylation and decreased mRNA expression of MAL, PRIMA1, PTGDR and SFRP1 in colorectal adenoma and cancer.
    Kalmár A; Péterfia B; Hollósi P; Galamb O; Spisák S; Wichmann B; Bodor A; Tóth K; Patai ÁV; Valcz G; Nagy ZB; Kubák V; Tulassay Z; Kovalszky I; Molnár B
    BMC Cancer; 2015 Oct; 15():736. PubMed ID: 26482433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of NS398 on metastasis-associated gene expression in a human colon cancer cell line.
    Gao XQ; Han JX; Huang HY; Song B; Zhu B; Song CZ
    World J Gastroenterol; 2005 Jul; 11(28):4337-43. PubMed ID: 16038031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential biomarkers of colorectal adenoma-dysplasia-carcinoma progression: mRNA expression profiling and in situ protein detection on TMAs reveal 15 sequentially upregulated and 2 downregulated genes.
    Galamb O; Sipos F; Spisák S; Galamb B; Krenács T; Valcz G; Tulassay Z; Molnár B
    Cell Oncol; 2009; 31(1):19-29. PubMed ID: 19096147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma, and normal tissue examined by oligonucleotide arrays.
    Notterman DA; Alon U; Sierk AJ; Levine AJ
    Cancer Res; 2001 Apr; 61(7):3124-30. PubMed ID: 11306497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COX2 inhibitor NS398 reduces HT-29 cell invasiveness by modulating signaling pathways mediated by EGFR and HIF1-α.
    Bocca C; Bozzo F; Miglietta A
    Anticancer Res; 2014 Apr; 34(4):1793-800. PubMed ID: 24692712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study on the effect of COX-2's selective inhibitor on human colorectal adenoma cells proliferation].
    Qiu C; Ouyang Q
    Zhonghua Nei Ke Za Zhi; 2001 Jun; 40(6):377-80. PubMed ID: 11798601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-surface markers for colon adenoma and adenocarcinoma.
    Sewda K; Coppola D; Enkemann S; Yue B; Kim J; Lopez AS; Wojtkowiak JW; Stark VE; Morse B; Shibata D; Vignesh S; Morse DL
    Oncotarget; 2016 Apr; 7(14):17773-89. PubMed ID: 26894861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide expression profiling in colorectal cancer focusing on lncRNAs in the adenoma-carcinoma transition.
    Kalmár A; Nagy ZB; Galamb O; Csabai I; Bodor A; Wichmann B; Valcz G; Barták BK; Tulassay Z; Igaz P; Molnár B
    BMC Cancer; 2019 Nov; 19(1):1059. PubMed ID: 31694571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colorectal adenoma to carcinoma progression is accompanied by changes in gene expression associated with ageing, chromosomal instability, and fatty acid metabolism.
    Carvalho B; Sillars-Hardebol AH; Postma C; Mongera S; Terhaar Sive Droste J; Obulkasim A; van de Wiel M; van Criekinge W; Ylstra B; Fijneman RJ; Meijer GA
    Cell Oncol (Dordr); 2012 Feb; 35(1):53-63. PubMed ID: 22278361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apoptosis induction and cyclooxygenase-2 regulation in human colorectal adenoma and carcinoma cell lines by the cyclooxygenase-2-selective non-steroidal anti-inflammatory drug NS-398.
    Elder DJ; Halton DE; Crew TE; Paraskeva C
    Int J Cancer; 2000 May; 86(4):553-60. PubMed ID: 10797271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic mRNA expression patterns of inflamed, benign, and malignant colorectal biopsy specimen and their correlation with peripheral blood results.
    Galamb O; Sipos F; Solymosi N; Spisák S; Krenács T; Tóth K; Tulassay Z; Molnár B
    Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2835-45. PubMed ID: 18843029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
    Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
    World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclooxygenase-2 inhibition prevents migration of colorectal cancer cells to extracellular matrix by down-regulation of matrix metalloproteinase-2 expression.
    Leung E; McArthur D; Morris A; Williams N
    Dis Colon Rectum; 2008 Mar; 51(3):342-7. PubMed ID: 18228100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-associated down-regulation of 15-lipoxygenase-1 is reversed by celecoxib in colorectal cancer.
    Heslin MJ; Hawkins A; Boedefeld W; Arnoletti JP; Frolov A; Soong R; Urist MM; Bland KI
    Ann Surg; 2005 Jun; 241(6):941-6; discussion 946-7. PubMed ID: 15912043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclooxygenase-2 inhibitor NS398 enhances antitumor effect of irradiation on hormone refractory human prostate carcinoma cells.
    Wen B; Deutsch E; Eschwege P; De Crevoisier R; Nasr E; Eschwege F; Bourhis J
    J Urol; 2003 Nov; 170(5):2036-9. PubMed ID: 14532848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenoma to carcinoma: A portrait of molecular and immunological profiles of colorectal sporadic tumors.
    Elsayed I; Li L; Sheahan K; Moran B; Bakheit S; Wang X
    Int Immunopharmacol; 2021 Nov; 100():108168. PubMed ID: 34562842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A gene expression and pre-mRNA splicing signature that marks the adenoma-adenocarcinoma progression in colorectal cancer.
    Pesson M; Volant A; Uguen A; Trillet K; De La Grange P; Aubry M; Daoulas M; Robaszkiewicz M; Le Gac G; Morel A; Simon B; Corcos L
    PLoS One; 2014; 9(2):e87761. PubMed ID: 24516561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinase-9 expression in the normal mucosa-adenoma-dysplasia-adenocarcinoma sequence of the colon.
    Herszényi L; Sipos F; Galamb O; Solymosi N; Hritz I; Miheller P; Berczi L; Molnár B; Tulassay Z
    Pathol Oncol Res; 2008 Mar; 14(1):31-7. PubMed ID: 18347934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.